Hui Wei

12PUBLICATIONS
39CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 27, 2026
Gene- and subtype-dependent prognostic impact of ras pathway mutations in acute myeloid leukemia: a cohort study of 2,500 patients.

|May 21, 2026
Venetoclax Plus Pediatric Regimen in Adolescents and Adults with Ph-Negative Acute Lymphoblastic Leukemia.

|May 14, 2026
CBFB::MYH11 MRD after the second chemotherapy cycle: a guide for allogeneic transplantation in favorable-risk AML.

|Apr 14, 2026
Pre-diagnostic clonal hematopoiesis of indeterminate potential among patients with a primary cancer and risk of second cancers.

Xinyuan Liu, Hans-Olov Adami, Erik Boberg

|Sep 05, 2025
Correction: Olverembatinib combined with venetoclax and reduced-intensity chemotherapy for adult newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center, single-arm, phase 2 trial.

Xiaoyuan Gong, Wenbing Liu, Yuntao Liu

|Aug 09, 2025
Single-cell transcriptome profiling reveals blast cell heterogeneity and identifies novel therapeutic target IKZF2 in t(8;21) acute myeloid leukaemia.

Yu Liu, Wenbing Liu, Yihan Mei

Pageof 2

Frequent Collaborators

8 joint publications

Jianxiang Wang

7 joint publications

Shaowei Qiu

5 joint publications

Ying Wang

4 joint publications

Kaiqi Liu